Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BEVACIZUMAB Cause Suspected counterfeit product? 65 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 65 reports of Suspected counterfeit product have been filed in association with BEVACIZUMAB (JOBEVNE). This represents 0.1% of all adverse event reports for BEVACIZUMAB.

65
Reports of Suspected counterfeit product with BEVACIZUMAB
0.1%
of all BEVACIZUMAB reports
6
Deaths
11
Hospitalizations

How Dangerous Is Suspected counterfeit product From BEVACIZUMAB?

Of the 65 reports, 6 (9.2%) resulted in death, 11 (16.9%) required hospitalization, and 1 (1.5%) were considered life-threatening.

Is Suspected counterfeit product Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BEVACIZUMAB. However, 65 reports have been filed with the FAERS database.

What Other Side Effects Does BEVACIZUMAB Cause?

Off label use (12,094) Death (8,493) Diarrhoea (4,911) Disease progression (4,653) Fatigue (4,572) Nausea (4,357) Hypertension (4,309) Anaemia (3,221) Vomiting (3,193) Neutropenia (2,875)

What Other Drugs Cause Suspected counterfeit product?

SILDENAFIL (283) SEMAGLUTIDE (191) MINOXIDIL (161) TADALAFIL (152) ORLISTAT (106) ALPRAZOLAM (90) OXYCODONE (81) RIVAROXABAN (58) LAMIVUDINE (48) AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (46)

Which BEVACIZUMAB Alternatives Have Lower Suspected counterfeit product Risk?

BEVACIZUMAB vs BEVACIZUMAB-AWWB BEVACIZUMAB vs BEVACIZUMAB-BVZR BEVACIZUMAB vs BEVACIZUMAB-MALY BEVACIZUMAB vs BEXAROTENE BEVACIZUMAB vs BEYAZ

Related Pages

BEVACIZUMAB Full Profile All Suspected counterfeit product Reports All Drugs Causing Suspected counterfeit product BEVACIZUMAB Demographics